The role of REV-ERB in NASH

Acta Pharmacol Sin. 2022 May;43(5):1133-1140. doi: 10.1038/s41401-022-00883-w. Epub 2022 Feb 25.

Abstract

REV-ERBs are atypical nuclear receptors as they function as ligand-regulated transcriptional repressors. The natural ligand for the REV-ERBs (REV-ERBα and REV-ERBβ) is heme, and heme-binding results in recruitment of transcriptional corepressor proteins such as N-CoR that mediates repression of REV-ERB target genes. These two receptors regulate a large range of physiological processes including several important in the pathophysiology of non-alcoholic steatohepatitis (NASH). These include carbohydrate and lipid metabolism as well as inflammatory pathways. A number of synthetic REV-ERB agonists have been developed as chemical tools and they show efficacy in animal models of NASH. Here, we will review the functions of REV-ERB with regard to their relevance to NASH as well as the potential to target REV-ERB for treatment of this disease.

Keywords: Heme; NASH; REV-ERB; circadian clock; inflammation; lipid and glucose metabolism.

MeSH terms

  • Animals
  • Circadian Rhythm / physiology
  • Heme / metabolism
  • Ligands
  • Non-alcoholic Fatty Liver Disease* / drug therapy
  • Nuclear Receptor Subfamily 1, Group D, Member 1*
  • Transcription Factors / metabolism

Substances

  • Ligands
  • Nuclear Receptor Subfamily 1, Group D, Member 1
  • Transcription Factors
  • Heme